MODULATION OF OVARIAN-CARCINOMA TUMOR-MARKER CA-125 BY GAMMA-INTERFERON
- 1 December 1989
- journal article
- research article
- Vol. 49 (23) , 6538-6542
Abstract
Interferons are known to modulate several cellular functions by the induction of different proteins. In our study a .gamma.-interferon-mediated presentation of one of the most important ovarian tumor markers (CA-125) on the cell surface was demonstrated using two ovarian carcinoma cell lines in vitro (HTB-77 and SKOV-3). This induction was found to be dependent on an intact protein biosynthesis. The .gamma.-interferon effect reached a maximum on the third day of treatment. Under such conditions the CA-125 concentration was increased intracellularly, on the cell surface, and in the supernatant culture medium. The surface antigen was shed rapidly with a half-life of 1 day. The addition of dexamethasone to .gamma.-interferon treated HTB-77 cells improved CA-125 expression synergistically. HLA-DR and CA-125 expression was found to be regulated by interferons in different ways. The demonstration of CA-125 expression provides an important insight into the potential regulatory mechanism governing this tumor marker. Since interferons are naturally occurring substances as well as therapeutically administered agents, it seems necessary to pay attention to possible tumor marker modulation.This publication has 24 references indexed in Scilit:
- Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.The Journal of Immunology, 1985
- EFFECTS OF HUMAN RECOMBINANT ALPHA-2 ARG-INTERFERON AND GAMMA-INTERFERON ON HUMAN-BREAST CANCER CELL-LINES - DISSOCIATION OF ANTIPROLIFERATIVE ACTIVITY AND INDUCTION OF HLA-DR ANTIGEN EXPRESSION1985
- INTRAPERITONEAL RECOMBINANT ALPHA-INTERFERON FOR SALVAGE IMMUNOTHERAPY IN STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC ONCOLOGY GROUP-STUDY1985
- Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigensEuropean Journal of Immunology, 1985
- Inhibition of the estradiol-induced growth of cultured human breast cancer cells by the anti-estrogens tamoxifen, desmethyl-tamoxifen, 4-hydroxy-tamoxifen and enclomipheneBiochemical Pharmacology, 1984
- INTERACTION OF MONOCLONAL-ANTIBODIES WITH CELL-SURFACE ANTIGENS OF HUMAN OVARIAN CARCINOMAS1984
- ENHANCED EXPRESSION OF SURFACE TUMOR-ASSOCIATED ANTIGENS ON HUMAN-BREAST AND COLON-TUMOR CELLS AFTER RECOMBINANT HUMAN-LEUKOCYTE ALPHA-INTERFERON TREATMENT1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Concomitant induction of the cell surface expression of Ia determinants and accessory cell function by a murine macrophage tumor cell line.The Journal of Experimental Medicine, 1982
- Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferonProceedings of the National Academy of Sciences, 1978